Flow Traders U.S. LLC decreased its position in Tema Heart & Health ETF (NASDAQ:HRTS – Free Report) by 67.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 18,263 shares of the company’s stock after selling 38,178 shares during the quarter. Flow Traders U.S. LLC owned 1.09% of Tema Heart & Health ETF worth $522,000 at the end of the most recent reporting period.
Separately, JPMorgan Chase & Co. acquired a new position in Tema Heart & Health ETF in the second quarter valued at about $63,000.
Tema Heart & Health ETF Trading Down 0.1%
NASDAQ HRTS opened at $34.61 on Thursday. The firm has a market cap of $53.65 million, a price-to-earnings ratio of 22.06 and a beta of 0.97. The company has a 50 day moving average of $33.56 and a 200-day moving average of $30.59. Tema Heart & Health ETF has a 1-year low of $25.32 and a 1-year high of $36.20.
Tema Heart & Health ETF Announces Dividend
About Tema Heart & Health ETF
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.
Recommended Stories
- Five stocks we like better than Tema Heart & Health ETF
- What is a Low P/E Ratio and What Does it Tell Investors?
- Market Momentum: 3 Stocks Poised for Major Breakouts
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Reasons Casey’s General Stores Will Continue Trending Higher
- Want to Profit on the Downtrend? Downtrends, Explained.
- Golden Cross Alert: 3 Stocks With Major Upside Potential
Want to see what other hedge funds are holding HRTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tema Heart & Health ETF (NASDAQ:HRTS – Free Report).
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
